← Leaderboards
Patrick D Lyden
University Of Southern California
$23,193,864
Attributed
$23,193,864
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,697,113 · 10
By mechanism
P50$9,046,969 · 3
U01$7,407,812 · 1
U24$5,217,660 · 2
R01$4,681,208 · 2
UG3$3,980,070 · 1
R21$363,394 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- William J Mack$8,437,400
- Neena Kapoor$708,111
- Thomas Hugh McNeill$2,791,378
- Aimee Shaw$0
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeStroke TherapyAnimalsIschemiaDesignClinical TrialsBaseThrombolysisPre-ClinicalIschemic StrokePar-1 ReceptorCellsDoseLaboratoriesNeuroprotective AgentsNeurovascular UnitMediatingAnimal ModelNational Institute Of Neurological Disorders And StrokeReceptorInnovationPeptide HydrolasesAwardEvaluation
Grant awards (48)
The NIH SPAN Coordinating Center$879,383
U24 · FY2025 · NS · contact PI
The NIH SPAN Coordinating Center$955,240
U24 · FY2024 · NS · contact PI
The NIH SPAN Coordinating Center$1,008,499
U24 · FY2023 · NS · contact PI
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)$3,980,070
UG3 · FY2022 · NS · contact PI
The NIH SPAN Coordinating Center$782,862
U24 · FY2021 · NS · contact PI
The NIH SPAN Coordinating Center$655,825
U24 · FY2020 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$323,949
R01 · FY2020 · NS · contact PI
The NIH SPAN Coordinating Center$166,993
U24 · FY2020 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$110,246
R01 · FY2020 · NS · contact PI
The NIH SPAN Coordinating Center$39,842
U24 · FY2020 · NS · contact PI
The NIH SPAN Coordinating Center$729,016
U24 · FY2019 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$435,725
R01 · FY2019 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$435,725
R01 · FY2018 · NS · contact PI
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke$802,698
U01 · FY2017 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$436,331
R01 · FY2017 · NS · contact PI
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke$1,988,556
U01 · FY2016 · NS · contact PI
Thrombin mediated cytotoxicity during cerebral ischemia$431,381
R01 · FY2016 · NS · contact PI
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke$2,176,709
U01 · FY2015 · NS · contact PI
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke$2,439,849
U01 · FY2014 · NS · contact PI
Thrombin Mediated Cytotoxicity during Cerebral Ischemia$361,660
R01 · FY2014 · NS · contact PI
Thrombin Mediated Cytotoxicity during Cerebral Ischemia$352,527
R01 · FY2013 · NS · contact PI
Thrombin Mediated Cytotoxicity during Cerebral Ischemia$365,313
R01 · FY2012 · NS · contact PI
Thrombin Mediated Cytotoxicity during Cerebral Ischemia$365,313
R01 · FY2011 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy (P50)$168,783
P50 · FY2009 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy (P50)$885,598
P50 · FY2008 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy$1,288,504
P50 · FY2007 · NS · contact PI
Core--Stroke team$161,064
P50 · FY2007 · NS · contact PI
Hypothermia$161,062
P50 · FY2007 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy$1,309,707
P50 · FY2006 · NS · contact PI
Role of Angiogenesis Following Stroke$261,048
R01 · FY2006 · NS · contact PI
Quantitation of Early Vascular Leakage after Stroke$163,039
R21 · FY2006 · NS · contact PI
Hypothermia$153,731
P50 · FY2006 · NS · contact PI
Core--Stroke team$153,731
P50 · FY2006 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy$66,221
P50 · FY2006 · NS · contact PI
Therapeutic Window for Acute Stroke Therapy$1,299,062
P50 · FY2005 · NS
Role of Angiogenesis Following Stroke$267,330
R01 · FY2005 · NS
Quantitation of Early Vascular Leakage after Stroke$200,355
R21 · FY2005 · NS
Core--Stroke team$154,271
P50 · FY2005 · NS
Hypothermia$154,271
P50 · FY2005 · NS
Therapeutic Window for Acute Stroke Therapy$1,194,159
P50 · FY2004 · NS
Role of Angiogenesis Following Stroke$267,330
R01 · FY2004 · NS
Core--Stroke team$149,269
P50 · FY2004 · NS
Hypothermia$149,269
P50 · FY2004 · NS
Therapeutic Window for Acute Stroke Therapy$63,000
P50 · FY2004 · NS
Therapeutic Window for Acute Stroke Therapy$1,228,215
P50 · FY2003 · NS
Angiogenesis Following Stroke$267,330
R01 · FY2003 · NS
Core--Stroke team$153,526
P50 · FY2003 · NS
Hypothermia$153,526
P50 · FY2003 · NS